Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
NE3107 in Adults With Neurological Symptoms of Long COVIDNCT06847191BIVIPhase 2Completed2026-08-06Actual
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainNCT06848348DWTXPhase 2Active not recruiting2026-12Estimated
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative ColitisNCT06850727Odyssey TherapeuticsPhase 2Recruiting2026-04Estimated
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 WeeksNCT06851559PHATPhase 2Active not recruiting2026-10Estimated
A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)NCT06864104KARDPhase 2Completed2026-01-12Actual
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationNCT068649884D Molecular TherapeuticsPhase 3Active not recruiting2027-06Estimated
An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101NCT06867107MSLEPhase 2Enrolling by invitation2027-09-30Estimated
C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCVNCT06868264AVIRPhase 3Active not recruiting2026-09Estimated
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)NCT06868628TLSAPhase 2Recruiting2027-04-01Estimated
A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain InjuryNCT06870240OGENPhase 2Not yet recruiting2026-01-01Estimated
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeNCT06872125STOKPhase 3Recruiting2027-03Estimated
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)NCT06873516EVMNPhase 2Completed2026-05-29Actual
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant DiseaseNCT06875128DCTHPhase 2Recruiting2029-05Estimated
A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating DisorderNCT06878976AXSMPhase 3Enrolling by invitation2027-12Estimated
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute PancreatitisNCT06880770Arrowhead PharmaceuticalsPhase 3Recruiting2029-03Estimated
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)NCT06881784RVMDPhase 3Recruiting2027-12-01Estimated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisNCT06887192MapLight TherapeuticsPhase 2Recruiting2027-12Estimated
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisNCT06890923TLSAPhase 2Recruiting2026-04-30Estimated
Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.NCT06892834Procter and GamblePhase 2Completed2025-06-19Actual
To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisNCT06901505Akebia TherapeuticsPhase 3Completed2026-08-12Actual
A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV InfectionNCT06903338VIRPhase 3Active not recruiting2026-12-31Estimated
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersNCT06906341Corcept TherapeuticsPhase 2Recruiting2026-08Estimated
A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta InfectionNCT06907290MIRMPhase 2, Phase 3Active not recruiting2029-05Estimated
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCNCT06908304Maia BiotechnologyPhase 3Recruiting2027-07-31Estimated
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic SeizuresNCT06908356Praxis Precision MedicinesPhase 2Recruiting2025-07Estimated
Study of Bitopertin in Participants With EPP or XLP (APOLLO)NCT06910358IRONPhase 3Active not recruiting2026-09Estimated
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral SupportNCT06910943Protara TherapeuticsPhase 2, Phase 3Recruiting2028-03Estimated
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman SyndromeNCT06914609IONSPhase 3Recruiting2027-08Estimated
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal CancerNCT06915025ImunonPhase 3Recruiting2032-10-31Estimated
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the AnkleNCT06915233Vericel CorporationPhase 3Recruiting2030-07Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.